ABDALLAH ALABADLA REMEMBERS THE NIGHT HE thought he was going to die. The college student had fled his home in Gaza City for Khan Younis, a place he thought would be safer. But soon after arriving, he found the city emptied of critical medical supplies.
"I went to every pharmacy in the area where I was staying, desperately looking for insulin," he said in a phone interview from Cairo, where he evacuated in March. "I thought I was going to die because I didn't find it. I don't know how to describe it. It was a horrible moment."
Alabadla, 23, was in his final semester at Al-Aqsa University, where he studied English literature before the October 7 attacks on Israel by Hamas and subsequent Israeli invasion of Gaza. He also has Type 1 diabetes and relies on taking insulin daily to stay alive.
Before the launch of Israel's offensive seeking to release the Israeli hostages and destroy Hamas, United Nations bodies estimated that up to 71,000 Palestinians in Gaza were living with diabetes as of November 2023. It is not known now how many of them have since fled or been killed.
Insulin is one of the medicines in "acute shortage" in Gaza, according to the World Health Organization, recalling a time before the advent of insulin therapy, when having diabetes-today considered a treatable condition-almost always meant a death sentence within a matter of days or weeks.
Alabadla and others say they have gone to extreme measures to survive the shortage. They now frequently switch between multiple types of insulin based on availability rather than what is recommended for their unique needs, use expired insulin or resort to insulin rationing-a potentially fatal practice.
Dr. Waseem Alzaanin is a physician in Deir al-Balah, in central Gaza. Like Alabadla, he has Type 1 diabetes.
Denne historien er fra August 02 - 09, 2024 (Double Issue)-utgaven av Newsweek Europe.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra August 02 - 09, 2024 (Double Issue)-utgaven av Newsweek Europe.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Falling for Romance
A new book, Nora Ephron at the Movies, celebrates the writer/director best known for her iconic rom-coms and strong female characters
Cracking the Norse Code
Walrus DNA has shown that Vikings were likely the first to have encountered Indigenous North Americans
Monumental Shift
The discovery of 165-million-year-old crystals Easter Island has upended the longheld notion of how the Earth's \"conveyor belt\" moves
'OUR FOREIGN POLICY AND DOMESTIC REFORMS ARE TWO SIDES OF THE SAME COIN'
It is a well-known fact across the globe that the North Korean regime is irrational and unpredictable, but we have been consistent in strengthening our defense posture against the threat from North Korea since the Korean War, and I believe that their conventional capability is much inferior to that of the Korean military.
'They Read My Eulogy As I Lay in an Open Grave'
Like Paris Hilton, Natasia Pelowski claims she was subjected to abuse at a teenage therapy program
Russian Economy Faces 'Burnout'
Vladimir Putin admits difficulties” as the country’s key interest rate reaches a historic high
China's 'Silent Chemical War'
The U.S. must investigate Beijing's role in the manufacturing of fentanyl that is killing Americans, says one mom whose daughter died after accidentally taking the illicit substance
HARSH HEADWINDS
President Yoon Suk Yeol's BATTLE to reform a South Korea beset with structural problems under the specter of an increasingly aggressive neighbor to THE NORTH
Bridget Everett
BRIDGET EVERETT NEVER THOUGHT SHE'D BE THE LEAD OF A TV SHOW. \"I come from the downtown world in New York, a cabaret singer, and these things just don't happen, you don't find yourself with three seasons of HBO.
Amber Ruffin
A LATE-NIGHT COMEDY SHOW ON CNN? YES, and it's a game show, too.
